Altered peripheral B-lymphocyte subsets in type 1 diabetes and latent autoimmune diabetes in adults

Diabetes Care

Volumn 39, Issue 3, 2016, Pages 434-440

  Deng, Chao ^a   Xiang, Yufei ^a   Tan, Tingting ^a   Ren, Zhihui ^a   Cao, Chuqing ^a   Huang, Gan ^a   Wen, Li ^b   Zhou, Zhiguang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CD19 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 10; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL COUNT; CELL DESTRUCTION; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; LATENT AUTOIMMUNE DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PERIPHERAL LYMPHOCYTE; SEX DIFFERENCE; TH1 CELL; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; AGED; CHILD; IMMUNOLOGY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; B-LYMPHOCYTE SUBSETS; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84962090272     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-1765     Document Type: Article

References (39)

1. Todd JA. Etiology of type 1 diabetes. Immunity 2010;32:457-467
2. Zhou Z, Xiang Y, Ji L, et al.; LADA China Study Group. Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study. Diabetes 2013;62:543-550
3. Leslie RD, Kolb H, Schloot NC, et al. Diabetes classification: grey zones, sound and smoke: Action LADA 1. Diabetes Metab Res Rev 2008;24: 511-519
4. Xiang Y, Zhou Z, Deng C, Leslie RD. Latent autoimmune diabetes in adults in Asians: similarities and differences between East and West. J Diabetes 2013;5:118-126
5. Diana J, Simoni Y, Furio L, et al. Crosstalk between neutrophils, B-1a cells and plasmacy-toid dendritic cells initiates autoimmune diabetes. Nat Med 2013;19:65-73
6. Attanavanich K, Kearney JF. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol 2004;172:803-811
7. Mariño E, Villanueva J, Walters S, Liuwantara D, Mackay F, Grey ST. CD4(+)CD25(+) T-cells control autoimmunity in the absence of β-cells. Diabetes 2009;58:1568-1577
8. Pescovitz MD, Greenbaum CJ, Bundy B, et al.; Type 1 Diabetes TrialNet Anti-CD20 Study Group. B-lymphocyte depletion with rituximab and β-cell function: two-year results. Diabetes Care 2014;37:453-459
9. Mariette X, Rouanet S, Sibilia J, et al. Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: a non-inferiority randomised controlled trial. Ann Rheum Dis 2014;73:1508-1514
10. Duxbury B, Combescure C, Chizzolini C. Rit-uximab in systemic lupus erythematosus: an up dated systematic review and meta-analysis. Lupus 2013;22:1489-1503
11. He D, Guo R, Zhang F, Zhang C, Dong S, Zhou H. Rituximab for relapsing-remitting multiple sclerosis. Cochrane Database Syst Rev 2013; 12:CD009130
12. Haas KM, Poe JC, Steeber DA, Tedder TF. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 2005;23:7-18
13. Amu S, Saunders SP, Kronenberg M, Mangan NE, Atzberger A, Fallon PG. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol 2010; 125:1114-1124
14. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008;28:639-650
15. Jeong YI, Hong SH, Cho SH, Lee WJ, Lee SE. Induction of IL-10-producing CD1dhighCD5+ regulatory B cells following Babesia microti-infection. PLoS One 2012;7:e46553
16. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoim-munitybyprovision of IL-10. Nat Immunol 2002; 3:944-950
17. Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 2009;182:7459-7472
18. Yoshizaki A, Miyagaki T, DiLillo DJ, et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 2012;491:264-268
19. Kaaba SA, Al-Harbi SA. Abnormal lymphocyte subsets in Kuwaiti patients with type-1 insulin-dependent diabetes mellitus and their first-degree relatives. Immunol Lett 1995;47: 209-213
20. Angelini F, Del Duca E, Piccinini S, Pacciani V, Rossi P, Manca Bitti ML. Altered phenotype and function of dendritic cells in children with type 1 diabetes. Clin Exp Immunol 2005;142: 341-346
21. Akesson C, Uvebrant K, Oderup C, et al. Altered natural killer (NK) cell frequency and phe-notype in latent autoimmune diabetes in adults (LADA) prior to insulin deficiency. Clin Exp Immunol 2010;161:48-56
22. Rodacki M, Svoren B, Butty V, et al. Altered natural killer cells in type 1 diabetic patients. Diabetes 2007;56:177-185
23. Valle A, Giamporcaro GM, Scavini M, et al. Reduction of circulating neutrophils precedes and accompanies type 1 diabetes. Diabetes 2013;62:2072-2077
24. Thompson WS, Pekalski ML, Simons HZ, et al. Multi-parametric flow cytometric and genetic investigation of the peripheral B cell compartment in human type 1 diabetes. Clin Exp Immunol 2014;177:571-585
25. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553
26. Hawa MI, Thivolet C, Mauricio D, et al.; Action LADA Group. Metabolic syndrome and autoimmune diabetes: Action LADA 3. Diabetes Care 2009;32:160-164
27. Petersen JS, Hejnaes KR, Moody A, et al. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple ra-dioligand assay. Diabetes 1994;43:459-467
28. Huang G, Xiang Y, Pan L, Li X, Luo S, Zhou Z. Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus. Diabetes Metab Res Rev 2013;29: 363-368
29. Evans JG, Chavez-Rueda KA, Eddaoudi A, et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 2007;178:7868-7878
30. Habib T, Funk A,Rieck M, et al. Altered Bcell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant. J Immunol 2012;188:487-496
31. Morbach H, Eichhorn EM, Liese JG, Girschick HJ. Reference values for B cell subpopulations from infancy to adulthood. Clin Exp Immunol 2010;162:271-279
32. Mariño E, Batten M, Groom J, et al. Marginal-zone β-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes 2008;57:395-404
33. Rodriguez-Calvo T, Ekwall O, Amirian N, Zapardiel-Gonzalo J, von Herrath MG. Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the path-ogenesis of type 1 diabetes. Diabetes 2014;63: 3880-3890
34. Serreze DV, Chapman HD, Niens M, et al. Loss of intra-islet CD20 expression may complicate efficacy of β-cell-directed type 1 diabetes therapies. Diabetes 2011;60:2914-2921
35. Menart-Houtermans B, Rütter R, Nowotny B, et al.; German Diabetes Study Group. Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German Diabetes Study (GDS). Diabetes Care 2014;37: 2326-2333
36. Carter NA, Rosser EC, Mauri C. Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis. Arthritis Res Ther 2012;14:R32
37. Kleffel S, Vergani A, Tezza S, et al. Inter-leukin-10+ regulatoryBcells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens. Diabetes 2015;64: 158-171
38. Xiang Y, Peng J, Tai N, et al. The dual effects of B cell depletion on antigen-specific T cells in BDC2.5NOD mice. J Immunol 2012;188: 4747-4758
39. Donath MY, Dalmas É, Sauter NS, Böni-Schnetzler M. Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity. Cell Metab 2013;17:860-872